# FDA 483 - Melanie M Hoppers, MD - December 15, 2022

Source: https://www.keypedia.com/records/483/melanie-m-hoppers-md/00a6e32f-2aec-4745-8fe6-8b8031a9a708

> FDA 483 for Melanie M Hoppers, MD on December 15, 2022. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Melanie M Hoppers, MD
- Inspection Date: 2022-12-15
- Product Type: drugs
- Office Name: New Orleans District Office
- Summary: An FDA inspection of Melanie M Hoppers, MD, a clinical investigator in Jackson, TN, revealed significant deficiencies in the conduct and supervision of a clinical study. The firm failed to ensure subject eligibility and was found to have altered laboratory reports, compromising data integrity. These issues indicate a serious lack of oversight in clinical trial practices.

## Related Officers

- [investigator](https://www.keypedia.com/people/ann-b-borromeo/ca03a531-043c-4195-b100-a8a0fc763159)

Company: https://www.keypedia.com/companies/melanie-m-hoppers-md/9135fced-541d-4c94-a266-4a1db20b1247

Office: https://www.keypedia.com/offices/new-orleans-district-office/95352142-b992-4e06-849d-d7483c0959ea